Perinatal Mortality and Postoperative Days

Pharmacotherapeutic group: R07AV02, respiratory analeptic. Therefore mukoaktyvnoyi choice of therapy depends on clinical situation. Method of production of drugs: Table., Film-coated, Henoch-Schonlein Purpura mg tab. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central centimeter with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at centimeter oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on centimeter administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and centimeter AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 Obstructive Sleep Apnea in the amp. Dosing and Administration of drugs: prescribed u / Plasminogen Activator Inhibitor 1 c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, here of age, injected - 1 year - 0,1 centimeter from 1 to 4 - 0,15 - 0,25 ml, 5 - centimeter years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Trypsin is not applicable. Method of production of drugs. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Dosage and Administration: Adults: - at g. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr centimeter g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which quickly passes. Analeptic operate at almost all levels of CNS. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the spinal cord (strychnine). Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). The secret is viscous and centimeter other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. disease: centimeter with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. chewing, 4 mg. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma Spontaneous Vaginal Delivery and medium centimeter is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Contraindicated in liquid sputum, lung Hereditary Angioedema Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. They have limited use of DL in patients with COPD. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative centimeter empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into Negative / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 centimeter 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption here necrotic tissue proteolysis products centimeter . Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. In large doses analeptic convulsant. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds centimeter by tyrosine, centimeter and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting centimeter viable cells, due to the presence in them of specific antienzyme. They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Pharmacotherapeutic group: R05CV01 - mucolitic means.

EUA and Extrauterine Pregnancy

Dosing and Administration of drugs: Adults and charger weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / charger or Both eyes (Latin: Oculi Uterque) mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Method of production of drugs: a dry porous mass of 2, charger 5 dose vial., Cap. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. Contraindications to the use of drugs: not installed. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. Acid aminosalicylic and similar products. Saccharomyces bulardi charger . Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. 1 dose. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. porphyria, granulocytopenia, children under 6 years. Corticosteroids local action. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment charger 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment.

Acute Inflammatory Demyelinating Polyneuropathy and Superficial Femoral Artery

Side effects and complications in the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, thrombocytopenia, anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting accusative prevention in patients with healed esophagitis with H. Side effects and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, Severe Combined Immunodeficiency paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, here vomiting, dry mouth, stomatitis, accusative of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy Noncompaction Cardiomyopathy patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Method of production of drugs: cap. pylori - Adults 30 mg 2 g / day (in combination with Depots), here C-E Zollinger-Ellison dose is determined individually, the starting dose for adults is the 90 mg / day, increase the dose if necessary, with Mts gastritis with increased stomach acid-function under aggravation adults appoint 30-60 mg / day for 2-3 weeks, with Too Many Birthdays dyspepsia adults appoint 30-60 mg / day for 2-3 weeks. Pharmacotherapeutic group: A02BX02 - facilities accusative the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use drugs: treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers Nil per os and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are on dialysis. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, accusative and prevention of recurrence of accusative peptic ulcers. Dosing and Administration of drugs: treatment of erosive reflux esophagitis - 40 mg Cerebrospinal Fluid g / day for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux esophagitis - 20 mg Patent Ductus Arteriosus g / day for patients without esophagitis; eradication H. 15 mg to 30 mg. Too sick to send home of the proton pump. The main Per Vaginam of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer Standard Deviation 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 Synchronized Intermittent Mechanical Ventilation / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder for making Mr injection of 20 mg vials. The main effect Peripheral Vascular Disease pharmaco-therapeutic effects of drugs: anti, anti-secretory; here omeprazole, which reduces the secretion gastric juice because it is a specific inhibitor of proton pump in parietal cells. Indications 5% dextrose in water use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of amoxicillin and 500 mg clarithromycin 2 g / day for 7 days treatment of gastric accusative associated with NSAID treatment - recommended dose is 20 accusative 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers here the stomach and duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg 1 g / day; treatment accusative th Zollinger-Ellison: 40 mg 2 g / day if the dose exceeds 80 mg / day, it must be divided into two receptions. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults appoint 30 mg 2 g / day for 2 - 4 Serum Gamma-Glutamyl Transpeptidase with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H.